Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.

Blood advances - 25 Jan 2022

Zátopková Martina, Ševčíková Tereza, Fanfani Viola, Chyra Zuzana, Říhová Lucie, Bezděková Renata, Žihala David, Growková Kateřina, Filipová Jana, Černá Lucie, Broskevičova Lucie, Kryukov Fedor, Minařík Jiří, Smejkalová Jana, Maisnar Vladimír, Harvanová Ĺubica, Pour Luděk, Jungova Alexandra, Popková Tereza, Bago Juli Rodriguez, Anilkumar Sithara Anjana, Hrdinka Matouš, Jelínek Tomáš, Šimíček Michal, Stracquadanio Giovanni, Hájek Roman

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Myeloma
Share to Mutation
Share to Neoplasm, Residual

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 34500459
DOI: 10.1182/bloodadvances.2020003876
PMCID: PMC8791596

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine.PMID 34500459Read ↗

Minimal residual disease in multiple myeloma: defining the role of next generation sequencing and flow cytometry in routine diagnostic useSemantic proximity Read ↗

miRNAs driving diagnosis, progression, and drug resistance in multiple myelomaSemantic proximity Read ↗

[Towards precision medicine in myeloma: new evidence and challenges].Semantic proximity Read ↗

Single-cell sequencing reveals the mechanisms of multiple myeloma progression: clarity or confusion?Semantic proximity Read ↗

The molecular characterization and clinical management of multiple myeloma in the post-genome eraSemantic proximity Read ↗

The Evolving Role of Genomic Technologies in Multiple Myeloma: Implications for Diagnosis, Risk Stratification and Resistance.Semantic proximity Read ↗

Molecular pathogenesis of multiple myeloma: basic and clinical updatesSemantic proximity Read ↗

Genomic Basis of Multiple Myeloma Subtypes from the MMRF CoMMpass StudySemantic proximity Read ↗

Comprehensive characterization of the mutational landscape in multiple myeloma cell lines reveals potential drivers and pathways associated with tumor progression and drug resistanceSemantic proximity Read ↗

Genomic Profiling to Contextualize the Results of Intervention for Smoldering Multiple Myeloma.Semantic proximity Read ↗

Single-cell profiling of tumour evolution in multiple myeloma — opportunities for precision medicineSemantic proximity Read ↗

Designing Evolutionary-based Interception Strategies to Block the Transition from Precursor Phases to Multiple Myeloma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.